Differential Expression of the Hyaluronan Receptors CD44 and RHAMM in Human Pancreatic Cancer Cells

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1607-1618

  Aßmann, Volker ^a   Kern, Horst Franz ^a   Elsässer, Hans Peter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HERMES ANTIGEN; HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONAN-MEDIATED MOTILITY RECEPTOR; MESSENGER RNA; RNA; SCLEROPROTEIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; BLOTTING, NORTHERN; DNA, COMPLEMENTARY; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0030222996     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Laurent, T. C., and Fraser, J. R. E. Hyaluronan. FASEB J., 6: 2997-2404, 1992.
2. Sherman, L., Sleeman, J., Herrlich, P., and Ponta, H. Hyaluronate receptors key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol., 6: 726-733, 1994.
3. Lesley, J., Hyman, R., and Kincade, P. W. CD44 and its interaction with the cellular matrix. Adv. Immunol., 54: 271-335, 1993.
4. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haußmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
5. Hofmann, M., Rudy, W , Zöller, M., Tölg, C., Ponta, H., Herrlich, P., and Gunthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51: 5292-5297, 1991.
6. Jackson, D. G., Buckley, J., and Bell, J. I. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem., 267: 4732-4739, 1992.
7. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
8. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell, 61: 1303-1313, 1990.
9. Miyake, K., Underhill, C. B., Lesley, J., and Kincade, P. W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med., 172: 69-75, 1990.
10. Culty, M., Miyake, K., Kincade, P. W., Silorski, E., Butcher, E. C., and Underhill, C. B. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol., 111: 2765-2774, 1990.
11. Carter, W. G., and Wayner, E. A. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells J. Biol. Chem., 263: 4193-4201, 1988.
12. Jalkanen, S., and Jalkanen, M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol., 116: 817-825, 1992.
13. Gallatin, W. M., Wayner, E. A., Hoffmann, P. A., St John, T., Butcher, E. C., and Carter, W. G. Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc. Natl. Acad. Sci. USA, 86: 4654-4658, 1989.
14. Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zöller, M., Heider, K.-H., Ponta, H , and Herrlich, P. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res., 53: 1262-1268, 1993
15. Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H , Herrlich, P., Matzku, S., and Zöller, M. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med., 177: 443-455, 1993.
16. Reber, S., Matzku, S., Gunthert, U., Ponta, H., Herrlich, P., and Zoller, M. Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int. J. Cancer, 46: 919-927, 1990.
17. Heider, K-H., Hofmann, M., Horst, E., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120: 227-233, 1993.
18. Wielenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53. 4754-4756, 1993.
19. Tanabe, K. K., Ellis, L. M., and Saya, H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases Lancet, 341: 725-726, 1993.
20. Matsumura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation Lancet, 340: 1053-1058, 1992.
21. Koopman, G., Heider, K-H., Horst, E., Adolf, G. R., van den Berg, F., Ponta, H , Herrlich, P., and Pals, S. T Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med., 177: 897-904, 1993.
22. Horst, E., Meijer, C. J. L. M., Radaszkiewicz, T., Ossekoppele, G. J., van Krieken, J. H. J. M., and Pals, S. T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1(CD11a/CD18), and ICAM-1 (CD54). Leukemia, 4: 595-599, 1990.
23. Heider, K-H., Dämmrich, J., Skroch-Angel, P., Müller-Hermelink, H-K., Vollmers, H. P., Herrlich, P., and Ponta, H. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53: 4197-4203, 1993.
24. Birch, M., Mitchell, S., and Hart, I. R. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res., 51: 6660-6667, 1991.
25. Turley, E. A., Austen, L., Vandeligt, K., and Clary, C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol., 112: 1041-1047, 1991.
26. Turley, E. A., Moore, D., and Hayden, L. J. Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells. Biochemistry, 26: 2997-3005, 1987.
27. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., Cripps, V., Austen, L., Nance, D. M., and Turley, E. A. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol., 117: 1343-1350, 1992.
28. Turley, E. A. Hyaluronan and cell locomotion. Cancer Metastasis Rev., 11: 21-30, 1992.
29. Hall, C. L., Wang, C., Lange, L. A., and Turley, E. A. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol., 126: 575-588, 1994.
30. Hall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., Greenberg, A. H., and Turley, E. A. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82: 19-28, 1995.
31. Mahlbacher, V., Sewing, A., Elsässer, H-P., and Kern, H. F. Hyaluronan is a secretory product of human pancreatic adenocarcinoma cells. Eur. J. Cell Biol., 58: 28-34, 1992.
32. Fries, H., Elsässer, H-P., Mahlbacher, V., Neumann, K., and Kern, H. F. Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein. Virchows Archiv., 424: 7-12, 1994.
33. Elsässer, H-P., Lehr, U., Agricola, B., and Kern, H. F. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch. B Cell Pathol., 61: 295-306, 1992.
34. Elsässer, H-P., Lehr, U., Agricola, B., and Kern, H. F. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma. Virchows Arch. B Cell Pathol., 64: 201-207, 1993.
35. Dürst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N. E., and Gissmann, L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene, 1: 251-256, 1987.
36. Stamenkovic, I., Amiot, M., Pesando, J. M., and Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56: 1057-1062, 1989.
37. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
38. Dalchau, R., Kirckley, J., and Fabre, J. W. Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W3/13 antigen of the rat. Eur. J. Immunol., 10: 745-749, 1980.
39. Mackay, C. R., Terpe, H-J., Stauder, R., Marston, Stark, H., and Günthert, U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124: 71-82, 1994.
40. Laemmli, U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond. ), 227: 680-685, 1970.
41. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1992.
42. Hagen, G., Müller, S., Beato, M., and Suske, G. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res., 20: 5519-5525, 1992.
43. Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10: 343-348, 1991.
44. Dougherty, G. J., Lansdorp, P. M., Cooper, D. L., and Humphries, R. K. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J. Exp. Med., 174: 1-5, 1991.
45. Dougherty, G. J., Cooper, D. L., Memory, J. F., and Chiu, R. K. Ligand binding specificity of alternatively spliced CD44 isoforms. J. Biol. Chem., 269: 9074-9078, 1994.
46. Yang, B., Yang, B. L., Savani, R. C., and Turley, E. A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J., 13: 286-296, 1994.
47. Peach, R. J., Hollenbaugh, D., Stamenkovic, I., and Aruffo, A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol., 122: 257-264, 1993.
48. Entwistle, J., Zhang, Sh., Yang, B, Wong, C., Li, Q., Hall, C. L., Jingbo, A., Mowat, M., Greenberg, A. H., and Turley, E. A. Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene (Amst.), 163: 233-238, 1995.
49. Turley, E. A., Belch, A. J., Poppema, S., and Pilarski, L. M. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood, 81: 446-453, 1993.
50. Nagy, J. I., Hacking, J., Frankenstein, U. N., and Turley, E. A. Requirement of the hyaluronan receptor RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell lines. J. Neurosci., 15: 241-252, 1995.
51. Terpe, H-J., Stark, H., Prehm, P., and Günthert, U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant fetal and adult tissues. Histochemistry, 101: 79-89, 1994.
52. Shtivelman, E., and Bishop, J. M. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol., 11: 5446-5453, 1991.
53. Favrot, M. C., Combaret, V., and Lasset, C. CD44 - a new prognostic marker for neuroblastoma. N. Engl. J. Med., 329: 1965, 1993.
54. Takada, M., Yamamoto, M., and Saitoh, Y. The significance of CD44 in human pancreatic cancer: I. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas, 9: 748-752, 1994.
55. Takada, M., Yamamoto, M., and Saitoh, Y. The significance of CD44 in human pancreatic cancer: H. The role of CD44in human pancreatic adenocarcinoma invasion. Pancreas, 9: 753-757, 1994.
56. Gansauge, F., Gansauge, S., Zobywalski, A., Scharnweber, C., Link, K. H., Nussler, A. K., and Beger, H. G. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res., 55: 5499-5503, 1995.
57. Rall, C. J. N., and Rustgi, A. K. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res., 55: 1831-1835, 1995.
58. Boudreau, N., Turley, E. A., and Rabinovitch, M. Fibronectin, hyaluronan and hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol., 143: 235-247, 1991.
59. Savani, R. C., Wang, C., Yang, B., Zhang, S., Kinsella, M. G., Wight, T. N., Stern, R., Nance, D. M., and Turley, E. A. Migration of bovine aortic smooth muscle cells after wounding injury. J. Clin. Invest., 95: 1158-1168, 1995.
60. Pilarski, L. M., Miszta, H., and Turley, E. A. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol., 150: 4292-4302, 1993.